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Abstract
Background: Gene doctoring is an efficient recombination-based genetic engineering approach to mutagenesis of
the bacterial chromosome that combines the λ-Red recombination system with a suicide donor plasmid that is
cleaved in vivo to generate linear DNA fragments suitable for recombination. The use of a suicide donor plasmid
makes Gene Doctoring more efficient than other recombineering technologies. However, generation of donor
plasmids typically requires multiple cloning and screening steps.
Results: We constructed a simplified acceptor plasmid, called pDOC-GG, for the assembly of multiple DNA
fragments precisely and simultaneously to form a donor plasmid using Golden Gate assembly. Successful constructs
can easily be identified through blue-white screening. We demonstrated proof of principle by inserting a gene for
green fluorescent protein into the chromosome of Escherichia coli. We also provided related genetic parts to assist
in the construction of mutagenesis cassettes with a tetracycline-selectable marker.
Conclusions: Our plasmid greatly simplifies the construction of Gene Doctoring donor plasmids and allows for the
assembly of complex, multi-part insertion or deletion cassettes with a free choice of target sites and selection
markers. The tools we developed are applicable to gene editing for a wide variety of purposes in Enterobacteriaceae
and potentially in other diverse bacterial families.
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Background
Over 10 years ago, Lee et al. [1] developed the gene doc-
toring approach for efficient mutagenesis of Escherichia
coli, targeting the λ-Red recombination system [2] to a
mutation cassette flanked by homologous regions and
released from a suicide donor plasmid by the I-SceI
meganuclease. Delivery of the mutagenesis cassette from
a plasmid rather than as a linear DNA fragment protects
the DNA from attack by host nucleases and leads to
higher-efficiency recombination. Since then, the
gene doctoring technique has been refined [3] and used
in other bacterial species, including Salmonella enterica
[4], Pseudomonas putida [5], and Klebsiella pneumoniae
[6]. However, construction of donor plasmids suitable
for gene doctoring typically relies on multiple, sequential
steps.
Golden Gate assembly [7, 8] provides a method for
one-step combinatorial DNA assembly which, we hoped,
could simplify construction of mutagenesis cassettes for
gene doctoring. We therefore set about creating a plas-
mid into which multiple genetic elements could be
inserted via a single Golden Gate reaction to produce a
Gene Doctoring donor plasmid. Our plasmid, pDOC-
GG, was based on pDOC-K from the original Gene Doc-
toring toolkit, but incorporated five changes to stream-
line the workflow from cloning to mutagenesis:
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1) To improve compatibility with existing Golden
Gate libraries, we changed the antibiotic resistance
marker on the donor plasmid from bla (ampicillin
resistance) to aph (3′)-Ia (kanamycin resistance).
2) We replaced the kanamycin resistance cassette of
pDOC-K with a lacZα drop-out cassette flanked by
BsaI restriction sites to create a Golden Gate
cloning region. Following cloning and
transformation, successful colonies can be identified
by blue-white screening [9] based upon loss of the
drop-out cassette.
3) We removed a BsaI site from the pDOC-K
backbone, between the HR2 cloning region and the
rrnB T1 terminator. This prevents interference from
off-target cleavage of the plasmid by BsaI during
cloning.
4) We removed both multiple cloning sites so that
only a minimal 34 bp FRT site will remain in the
chromosome following removal of a resistance
marker [10].
5) We reduced the size of the plasmid backbone, to
help avoid problems with transformation and
stability of a large plasmid prior to mutagenesis.
Results
By a combination of PCR and chemical synthesis, we ob-
tained five linear DNA fragments encoding the necessary
elements for pDOC-GG. Three fragments were derived
from pDOC-K, while the other two encoded the new aph
(3′)-Ia kanamycin resistance gene and the lacZα drop-out
cassette. We then constructed pDOC-GG by ligating these
fragments using Gibson assembly (Fig. 1) [11].
To construct a Gene Doctoring donor plasmid, a mu-
tagenesis cassette is built from blocks of DNA with de-
fined functions (known as genetic parts in the synthetic
biology terminology) by Golden Gate assembly, replacing
the lacZα cassette. Each mutagenesis cassette should
begin with the first homologous region (HR1), ligated at
its 5′ end to a CTAC BsaI overhang on pDOC-GG, and
end with the second homologous region (HR2), ligated
at its 3′ end to an ACGA overhang on pDOC-GG. Large
numbers of intervening genetic parts can be assembled
by designing them with sequential, overlapping BsaI
overhangs. After verifying the correct sequence of the
mutagenesis cassette, the donor plasmid can then be
used for Gene Doctoring as described by Lee et al. [1].
In verifying the full sequence of pDOC-GG, we identi-
fied two inconsistencies from the previously published
pDOC-K sequence: a deletion of a T at bp 4268 and a
23 bp insertion starting at bp 4336 (both numbered and
with reference to pDOC-K). Since neither of the varia-
tions are in a coding or regulatory region, and since they
are present in the original, widely used, Gene Doctoring
plasmid we have no reason to suspect that they are
significant for the function of the plasmid. We con-
firmed the function of pDOC-GG in E. coli by growth in
the presence of kanamycin and generation of blue col-
onies in the presence of 5-bromo-4-chloro-3-indolyl-β-
D-galactopyranoside (X-gal) and isopropyl β-D-1-thio-
galactopyranoside (IPTG).
We also produced two plasmid-borne genetic parts con-
sisting of a tetracycline resistance cassette (tetA gene with
a promoter and terminator) with different BsaI overhangs,
flanked by FRT sites, in an AmpR variant of mUAV [12].
These simplify the design of chromosomal insertions with
the scar sequence on either side of the insertion to minim-
ise polar effects on surrounding genes after removal of the
tetA cassette by Flp recombinase (Fig. 2) [13].
To test the function of pDOC-GG for cloning and mu-
tagenesis, we used it to insert sfgfp, encoding superfolder
green fluorescent protein (sfGFP) into a highly con-
served chromosomal locus downstream of the glmS gene
of E. coli (referred to here as the glmS site), where fitness
impacts from disruption are known to be minimal in
multiple species [14–16]. Our mutagenesis cassette used
one of the new tetA genetic parts immediately after
HR1, followed by sfgfp in the reverse orientation relative
to glmS (Fig. 2). Following Golden Gate cloning, we ob-
tained almost exclusively white colonies on plates con-
taining kanamycin, tetracycline, X-gal and IPTG. The
white colonies fluoresced green under a blue-light lamp
and developed a green colour following prolonged incu-
bation (~ 24 h), confirming the function of sfgfp. All the
green colonies (6/6) picked for screening by colony PCR
with primers pDOC-K_F and pDOC-K_R had inserts of
the expected length.
We purified the donor plasmid from one of the suc-
cessful colonies and used it, together with pACBSCE [1],
for mutagenesis by Gene Doctoring. We confirmed suc-
cessful integration of tetA and sfgfp into the chromo-
some by colony PCR using primers glmS_screen_F and
glmS_screen_R (Table 2). Out of 50 randomly chosen
colonies screened, 43 (86%) grew on LB agar with tetra-
cycline and sucrose and gave a colony PCR product of
the expected size in agarose gel electrophoresis (Supple-
mentary Figure 1). This compares favourably with the
90–93% integration efficiency (depending on the gene)
reported for E. coli MG1655 by Lee et al [1]. The slight
reduction in efficiency in our experiments is probably
due to the larger mutagenesis fragment required for in-
sertion of sfgfp plus a selection cassette rather than only
the selection cassette required for the gene knockouts
performed in the original paper.
Successful colonies were white and did not noticeably
fluoresce under blue light, both before and after removal
of the tetracycline resistance cassette (Fig. 3). However,
the cells fluoresced green when viewed by fluorescence
microscopy, confirming the function of the
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chromosomal insertion. The reduction in green color-
ation for cells with sfgfp on the chromosome is due to
the lower gene copy number compared to expression
from a plasmid. We performed whole-genome shotgun
sequencing on the final, tetracycline-sensitive cells to
confirm the correct location and sequence of the sfgfp
insertion, the absence of off-target recombination events
and the loss of all plasmids (Supplementary Figure 2).
Discussion
Gene Doctoring is a convenient and efficient variation of
recombineering, especially for non-domesticated and
pathogenic strains of E. coli, which are often not
amenable to transformation by the linear double-
stranded DNA required by other methods. pDOC-GG
harnesses Golden Gate assembly for single-reaction con-
struction of donor plasmids, thus increasing the utility
of Gene Doctoring by removing the number of cloning
steps required to generate the donor plasmid, while
retaining the advantages of the original system (Fig. 4).
Our approach also theoretically allows a free choice of
target sites, selection cassettes and type of modification
(insertions, deletions, inversions, replacements and point
mutations), while allowing integration with existing gen-
etic part libraries, including those conforming to the
popular MoClo molecular parts standard [17].
Fig. 1 Construction of pDOC-GG and its use to produce Gene Doctoring donor plasmids and perform chromosomal modifications. The first three
stages describe the production of pDOC-GG. 1) Three DNA fragments (brown arrows) were designed, based on pDOC-K, to form the backbone of
pDOC-GG. Significant features of pDOC-K are displayed. White boxes represent multiple cloning sites (MCS) 1 and 2; dark green arrows represent
PCR primers sacB_GA_F and sacB_GA_R used to obtain fragment pDOC_sacB. Other fragments were produced by chemical synthesis. 2) Full
features of the three fragments designed from pDOC-K and two further fragments to introduce new genetic elements. Light green arrows
represent promoters. 3) Significant features of pDOC-GG, which was produced by Gibson assembly of the five fragments. The last three stages
describe the construction of mutagenesis cassettes in pDOC-GG, and use of the resulting donor plasmid for Gene Doctoring. 4) BsaI overhangs
(coloured boxes) for homologous regions (HR) 1 and 2 should be complementary to the CTAC and ACGA overhangs generated on pDOC-GG.
Multiple intervening parts (Pt. A – X) are assembled sequentially by design of appropriate complementary BsaI overhangs. 5) and 6) The donor
plasmid is used for Gene Doctoring as described by Lee et al. [1]
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Although we have retained the original Flp
recombinase-based technique for removal of the se-
lectable marker in our experiments, scarless genome
editing is possible using tetA as a counterselection
marker [18]. Alternatively, any other selectable
marker(s) can be used instead, to suit individual ex-
perimental requirements [19–23]. Regions HR1 and
HR2 will vary between experiments and can easily be
produced either as chemically synthesised DNA frag-
ments, PCR products (with BsaI sites included on the
primers) or from genetic parts libraries. We have
made pDOC-GG publicly available, together with our
ampR version of mUAV and our genetic parts for in-
clusion of a tetA selection cassette on either side of
an insertion (Table 1). We encourage further modifi-
cation and sharing of these plasmids to broaden the
available toolkit for Gene Doctoring of diverse targets
and species with minimal effort.
Materials and methods
Bacterial strains
E. coli NEB5α (New England BioLabs product № C2987)
or NEB10β (New England BioLabs product № C3019)
cells were used as hosts during plasmid construction.
Genome manipulations were performed on E. coli strain
AW405 (a K-12 derivative), which was a gift from How-
ard Berg (Harvard University) [24].
Competent cell production and transformation
E. coli competent cells were prepared following the
CaCl2 method of Sambrook et al. [25] and transformed
by heat-shock at 42 °C for 45 s followed by recovery in
SOC medium.
Construction of pDOC-GG
Beginning with pDOC-K, we engineered substantial
modifications to produce a golden gate acceptor
Fig. 2 Schematic overview of the design of Gene Doctoring mutagenesis cassettes in pDOC-GG, using our donor vector for insertion of sfgfp into
the glmS site of E. coli as an example. Golden Gate assembly is used to replace the lacZα cassette with the DNA sequence that will form the
linear recombination fragment upon digestion with I-SceI in vivo. The top mutagenesis cassette shows the sequence that we assembled, with
tetA upstream of sfgfp. The bottom cassette shows an alternative design, using our second tetA genetic part to locate the FRT scar sequence
downstream of sfgfp. Mutagenesis cassettes are always flanked by homologous regions (HR1 and HR2) to direct them to the correct location in
the chromosome. By designing appropriate 4-bp BsaI overhangs (vertical text), the number and order of the DNA parts can be varied as desired
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plasmid, named pDOC-GG, to enable single-step con-
struction of donor plasmids. A 3308 bp DNA fragment
containing the sacB expression cassette was amplified
from pDOC-K by PCR with primers sacB_GA_F and
sacB_GA_R (Fig. 1, Table 2) to add overlap regions for
Gibson assembly. Four further fragments were then pur-
chased as gBlocks from IDT (Leuven, Belgium). These
fragments were a KanR cassette, the pMB1 and 5′ I-SceI
recognition sequence, a lacZα reporter gene with flank-
ing BsaI sites, and the 3′ I-SceI fragment (Fig. 1, Table 2).
Each fragment was designed with appropriate sequences
at each end to generate overlapping regions between
neighbouring fragments for Gibson assembly. The Gib-
son assembly reaction contained 12 fmol of the sacB
fragment, 10 fmol of the kanamycin resistance fragment,
50 fmol of the 3′ fragment and 20 fmol each of the
remaining fragments in 5.5 μL, and an equal volume of
2× Gibson assembly master mix (NEB, Hitchin, UK).
The reaction was incubated at 50 °C for 60 min, then
5 μL were used to transform NEB5α chemically
Fig. 3 Comparison of cell phenotypes at key stages of the Gene Doctoring procedure to insert sfgfp. Fluorescence microscopy images are
overlays of phase contrast and fluorescent images (488 nm excitation filter) at 1000× magnification
Fig. 4 Comparison of the major steps in assembly of donor plasmids using the original Gene Doctoring plasmids and our pDOC-GG
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competent cells, which were plated on LB agar contain-
ing kanamycin (50 μg.mL− 1), IPTG (1mM) and X-gal
(20 μg.mL− 1). Five blue colonies were selected and the
plasmids were sequenced.
Cloning of genetic parts
The genes for sfGFP and TetR were cloned into plasmids
to create genetic parts for Golden Gate assembly. The
sfgfp gene was amplified together with its promoter and
terminator by PCR using Q5 DNA polymerase (NEB,
Hitchin, U.K.) and primers J23106_FOR and sfGFPterm_
REV (Table 2) according to the manufacturer’s instruc-
tions. The template was plasmid pMA_Level2A [12].
The primers were designed to add BsaI sites for 5′
AGGT and 3′ CGCT overhangs, which caused sfgfp to
be inserted in the reverse orientation relative to glmS.
The PCR product was gel purified and then cloned into
pMiniT 2.0 using a PCR cloning kit (NEB, Hitchin, U.K.)
with NEB10β competent cells according to the manufac-
turer’s instructions. The tetracycline resistance cassettes
were cloned into an ampicillin-resistant variant of plas-
mid mUAV from the Mobius Assembly Vector Toolkit
(Addgene kit #1000000134) [12]. The β-lactamase (bla)
gene was amplified by PCR from pMiniT 2.0 using
primers Pbla_F_AatII and Pbla_R_SacI (Table 2),
digested with AatII and SacI, and ligated to mUAV line-
arized with the same enzymes. Correct constructs were
identified by colony PCR with primers mUAV_AmpR_
screen_F and mUAV_AmpR_screen_R (Table 2). The
new plasmid was named mUAVbla. The tetracycline re-
sistance cassettes were each synthesized as two halves
(Table 2) with AarI recognition sites to ligate them into
mUAVbla as a full coding sequence, complete with pro-
moter, terminator and flanking FRT sites, in a Golden
Gate reaction, according to Andreou & Nakayama, [12]
resulting in mUAVbla:tetR 5′ and mUAVbla:tetR 3′.
Plasmids containing tetA were identified phenotypically
and by colony PCR using primers pBRforEco and L4440
(Table 2), and the sequences of the plasmids were veri-
fied before use.
Golden Gate assembly of gene doctoring donor plasmids
Donor plasmids were created from pDOC-GG in a Golden
Gate assembly reaction using 10 fmol each of pDOC-GG
and pre-cloned DNA sequences and 20 fmol of chemically
synthesized sequences, 1 μLT4 DNA ligase buffer,
200 μg.mL− 1 bovine serum albumin, 0.5 μLT4 DNA ligase
(NEB, Hitchin, U.K.) and 0.5 μL BsaI-HF v2 (NEB, Hitchin,
U.K.) in a 10 μL reaction. The reaction consisted of 30 cycles
of 37 °C for 3min and 16 °C for 4min followed by an incu-
bation at 50 °C for 5min and finally at 80 °C for 5min.
NEB5α cells were transformed using 2 μL of the reaction
mix and white colonies growing on LB agar containing kana-
mycin (50 μg.mL− 1), tetracycline (10 μg.mL− 1), IPTG (500
mM) and X-gal (20 μg.mL− 1) were picked for screening.
Gene doctoring
For induction of chromosomal integrations, the strain to
be modified was transformed with the pDOC-GG-derived
donor plasmid and the pACBSCE helper plasmid carrying
the λ-Red genes. A single colony carrying both plasmids
was grown in 500 μL of Miller’s LB medium with appro-
priate antibiotics at 37 °C for 4 h. The cells were pelleted
and washed three times in filter sterilized 0.1× LB. They
were then resuspended in 500 μL of 0.1× LB supple-
mented with 0.5% arabinose and incubated at 37 °C for 2–
3 h for induction. 100 μL were plated on LB plates supple-
mented with tetracycline (10 μg.mL− 1) and 5% sucrose.
The plates were incubated at room temperature for 48–
72 h. Single colonies were checked for sfgfp insertion by
colony PCR with primers glmS screen F and glmS screen
R, annealing either side of the region to be modified. Ab-
sence of Gene Doctoring plasmids was checked by patch-
ing colonies to LB agar plates containing appropriate
antibiotics and an index plate containing no antibiotic.
Antibiotic resistance cassette removal
For the removal of the tetracycline resistance cassette,
AW405::tetA-sfgfp was transformed with plasmid pCP20,
carrying the genes for Flp recombinase activity, [13] and
recovered at 30 °C on LB agar plates supplemented with
carbenicillin (50 μg.mL− 1). Antibiotic cassette removal
Table 1 Genetic tools constructed during this study and made publicly available
Plasmid Description Addgene accession #
pDOC-GG Acceptor plasmid for Golden Gate-style cloning of gene fragments to generate any Gene
Doctoring donor plasmid in a single reaction.
149377
mUAVbla Derivative of the universal acceptor vector from the Mobius Assembly toolkit [12], conferring
an ampicillin resistance phenotype rather than chloramphenicol resistance.
149378
mUAVbla:tetR 5′ Gene part with a tetracycline resistance selectable marker flanked by FRT sites for BsaI-guided
Golden Gate assembly. Removal from the chromosome will leave an FRT scar between
homologous region 1 and an inserted sequence.
149379
mUAVbla:tetR 3′ Gene part with a tetracycline resistance selectable marker flanked by FRT sites for BsaI-guided
Golden Gate assembly. Removal from the chromosome will leave an FRT scar between an
inserted sequence and homologous region 2.
149380
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Table 2 Primers and chemically synthesized DNA fragments used in this study
Primer/fragment name Sequence
Primers
pDOC-K_F CATGATTACGCCAAGCTCTAG
pDOC-K_R GGGTTTTCCCAGTCACGACGT
sacB_GA_F GGTAGTGTGGCGAGAGTAGGGAACTGCCAG
sacB_GA_R CCAATTCTGACACATTTCCCCGAAAAGTGCC
J23106_FOR CACCACAGGTCTCGACCTTTTACGGCTAGCTCAGTCC
sfGFPterm_REV CACCACAGGTCTCGCGCTGTGACTCTAGTAGAGAGCG
Pbla_F_AatII ATATATGACGTCGCGGAACCCCTATTTGTTTA
Pbla_R_SacI ATATATGAGCTCTTACCAATGCTTAATCAGTGAG
mUAV_AmpR_screen_F TGCATATAGAGACCGAATTCC
mUAV_AmpR_screen_R CTTGGTCTGACAGCTCG
pBRforEco AATAGGCGTATCACGAGGC
L4440 AGCGAGTCAGTGAGCGAG
glmS screen F ACAAACGCATTGAAGCGCTG
glmS screen R GAACCGATACCCTGGTAGTTA
DNA fragments
pDOC_kan ACTTTTCGGGGAAATGTGTCAGAATTGGTTAATTGGTTGTAACACTGACCCC
TATTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAGACAATA
ACCCTGATAAATGCTTCAATAATATTGAAAAAGGAAGAATATGAGCCATATT
CAACGGGAAACGTCGAGGCCGCGATTAAATTCCAACATGGATGCTGATTTATATG
GGTATAAATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACAATCTATCG
CTTGTATGGGAAGCCCGATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGTA
GCGTTGCCAATGATGTTACAGATGAGATGGTCAGACTAAACTGGCTGACGGAATT
TATGCCACTTCCGACCATCAAGCATTTTATCCGTACTCCTGATGATGCATGGTTA
CTCACCACTGCGATCCCCGGAAAAACAGCGTTCCAGGTATTAGAAGAATATCCT
GATTCAGGTGAAAATATTGTTGATGCGCTGGCAGTGTTCCTGCGCCGGTTGCAC
TCGATTCCTGTTTGTAATTGTCCTTTTAACAGCGATCGCGTATTTCGCCTCGCTCA
GGCGCAATCACGAATGAATAACGGTTTGGTTGATGCGAGTGATTTTGATGACGAG
CGTAATGGCTGGCCTGTTGAACAAGTCTGGAAAGAAATGCATAAACTTTTGCCATT
CTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCACTTGATAACCTTATTTTT
GACGAGGGGAAATTAATAGGTTGTATTGATGTTGGACGAGTCGGAATCGCAGAC
CGATACCAGGATCTTGCCATCCTATGGAACTGCCTCGGTGAGTTTTCTCCTTCATTA
CAGAAACGGCTTTTTCAAAAATATGGTATTGATAATCCTGATATGAATAAATTGCA
GTTTCATTTGATGCTCGATGAGTTTTTCTAACTGTCAGACC
pDOC_ori GTTTTTCTAACTGTCAGACCAAGTTTACTCATATATACTTTAGATTGATTTAAAACTTCA
TTTTTAATTTAAAAGGATCTAGGTGTTTGATAATCTCATGACCAAAATCCCTTAACGTGA
GTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTGAGATCC
TTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTT
GTTTGCCGGATCAAGAGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAG
ATACCAAATACTGTCCTTCTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGC
ACCGCCTACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAA
GTCGTGTCTTACCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCAGCGGTCGG
GCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCGAACTGA
GATACCTACAGCGTGAGCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGACA
GGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGAA
ACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTG
TGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGCCTTT
TTACGGTTCCTGGCCTTTTGCTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCC
CTGATTCTGTGGATAACCGTACAGGAAACAGCTATGACCATGATTACGCCAAGCTCT
AGGGATAACAGGGTAATCTACTGAGA
pDOC_lacZ CAGGGTAATCTACTGAGACCTAATGTGAGTTAGCTCACTCATTAGGCACCCCAGG
CTTTACACTTTATGCTTCCGGCTCGTATGTTGTGTGGAATTGTGAGCGGATAACA
ATTTCACACAGGAAACAGCTATGACCATGATTACGTCGGATTCACTGGCCGTCGTT
TTACAACGTCGTGACTGGGAAAACCCTGGCGTTACCCAACTTAATCGCCTTGCAGC
ACATCCCCCTTTCGCCAGCTGGCGTAATAGCGAAGAGGCCCGCACCGATCGCCCTTC
CCAACAGTTGCGCAGCCTGAATGGCGAATGGCGCCTGATGCGGTATTTTCTCCTTAC
GCATCTGTGCGGTATTTCACACCGCATATGGTGCACTCTCAGTACAATCTGCTCTGA
TGCCGCATAGTTAAGCCAGCCCCGACACCCGCCAACACCCGCTGACGCGCCCTGAC
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Table 2 Primers and chemically synthesized DNA fragments used in this study (Continued)
Primer/fragment name Sequence
GGGCGGTCTCAACGATAGGGATAA
pDOC_I-SceI TCTCAACGATAGGGATAACAGGGTAATGAGCTTGGCACTGGCCGTCGTTTTACAACG
TCGTGACTGGGAAAACCCTGGCGTTACCCAACTTAATCGCCTTGCAGCACATCCCCC
TTTCGCCAGCTGGCGTAATAGCGAAGAGGCCCGCACCGATCGCCCTTCCCAACAGTT
GCGCAGCCTGAATGGCGAATGGCGAGCTTGGCTGTTTTGGCGGATGAGAGAAGATT
TTCAGCCTGATACAGATTAAATCAGAACGCAGAAGCGGTCTGATAAAACAGAATTTG
CCTGGCGGCAGTAGCGCGGTGGTCCCACCTGACCCCATGCCGAACTCAGAAGTGAA
ACGCCGTAGCGCCGATGGTAGTGTGGCGAGAGTAGGGAACTGCC
TetR 3′ part 1 TCACCTGCATATCTCTCGCTGAAGTTCCTATACTTTCTAGAGAATAGGAACTTCGGAAT
AGGAACTTCTAGAACTTATCCTAATTTTTGTTGACACTCTATCATTGATAGAGTTATTT
TACCACTCCCTATCAGTGATAGAGAAAAGTGAAATGAATAGTTCGACAAAGATCGCA
TTGGTAATTACGTTACTCGATGCCATGGGGATTGGCCTTATCATGCCAGTCTTGCCAAC
GTTATTACGTGAATTTATTGCTTCGGAAGATATCGCTAACCACTTTGGCGTATTGCTTG
CACTTTATGCGTTAATGCAGGTTATCTTTGCTCCTTGGCTTGGAAAAATGTCTGACCGA
TTTGGTCGGCGCCCAGTGCTGTTGTTGTCATTAATAGGCGCATCGCTGGATTACTTATT
GCTGGCTTTTTCAAGTGCGCTTTGGATGCTGTATTTAGGCCGTTTGCTTTCAGGGATCAC
AGGAGCTACTGGGGCTGTCGCGGCATCGGTCATTGCCGATACCACCTCAGCTTCTCAA
CGCGTGAAGTGGTTCGGTTGGTTAGGGGCAAGTTTTGGGCTTGGTTTAATAGCGGGGC
CTATTATTGGTGGTTTTGCAGGAGAGATTTCACCGCATAGTCCCTTTTTTATCGCTGCGTT
GCTAAATATTGTCACTTTCCTTGTGGTTATGTTTTGGTTCCGTGAAACCAAAAATACACG
TGATAATACAGATACCGAAGTAGGGGTTGAGACGCAATCATATGCAGGTGT
TetR 3′ part 2 TCACCTGCATATAATCGAATTCGGTATACATCACTTTATTTAAAACGATGCCCATTTTGTT
GATTATTTATTTTTCAGCGCAATTGATAGGCCAAATTCCCGCAACGGTGTGGGTGCTATT
TACCGAAAATCGTTTTGGATGGAATAGCATGATGGTTGGCTTTTCATTAGCGGGTCTTGG
TCTTTTACACTCAGTATTCCAAGCCTTTGTGGCAGGAAGAATAGCCACTAAATGGGGC
GAAAAAACGGCAGTACTGCTCGGATTTATTGCAGATAGTAGTGCATTTGCCTTTTTAGCGTT
TATATCTGAAGGTTGGTTAGTTTTCCCTGTTTTAATTTTATTGGCTGGTGGTGGGATCGCTTT
ACCTGCATTACAGGGAGTGATGTCTATCCAAACAAAGAGTCATCAGCAAGGTGCTTTAC
AGGGATTATTGGTGAGCCTTACCAATGCAACCGGTGTTATTGGCCCATTACTGTTTGCTGT
TATTTATAATCATTCACTACCAATTTGGGATGGCTGGATTTGGATTATTGGTTTAGCGTTTT
ACTGTATTATTATCCTGCTATCGATGACCTTCATGTTAACCCCTCAAGCTCAGGGGAGTAA
ACAGGAGACAAGTGCTTAGTAAGCGGGACTCTGGGGTTCGAAATGACCGACGGCTCA
CCTTCGGGTGGGCCTTTCTGCGAGGAAGTTCCTATACTTTCTAGAGAATAGGAACTTCA
GGTTGA GATATGCAGGTGT
TetR 5′ part 1 TCACCTGCATATCTCTGGAGGAAGTTCCTATACTTTCTAGAGAATAGGAACTTCGGAATAG
GAACTTCTAGAACTTATCCTAATTTTTGTTGACACTCTATCATTGATAGAGTTATTTTACCAC
TCCCTATCAGTGATAGAGAAAAGTGAAATGAATAGTTCGACAAAGATCGCATTGGTAATT
ACGTTACTCGATGCCATGGGGATTGGCCTTATCATGCCAGTCTTGCCAACGTTATTACGT
GAATTTATTGCTTCGGAAGATATCGCTAACCACTTTGGCGTATTGCTTGCACTTTATGCGTT
AATGCAGGTTATCTTTGCTCCTTGGCTTGGAAAAATGTCTGACCGATTTGGTCGGCGCCCAG
TGCTGTTGTTGTCATTAATAGGCGCATCGCTGGATTACTTATTGCTGGCTTTTTCAAGTGCGCT
TTGGATGCTGTATTTAGGCCGTTTGCTTTCAGGGATCACAGGAGCTACTGGGGCTGTCGCGGC
ATCGGTCATTGCCGATACCACCTCAGCTTCTCAACGCGTGAAGTGGTTCGGTTGGTTAGGGG
CAAGTTTTGGGCTTGGTTTAATAGCGGGGCCTATTATTGGTGGTTTTGCAGGAGAGATTTCAC
CGCATAGTCCCTTTTTTATCGCTGCGTTGCTAAATATTGTCACTTTCCTTGTGGTTATGTTTTGG
TTCCGTGAAACCAAAAATACACGTGATAATACAGATACCGAAGTAGGGGTTGAGACGCAAT
CATATGCAGGTGT
TetR 5′ part 2 TCACCTGCATATAATCGAATTCGGTATACATCACTTTATTTAAAACGATGCCCATTTTGTTGAT
TATTTATTTTTCAGCGCAATTGATAGGCCAAATTCCCGCAACGGTGTGGGTGCTATTTACCGA
AAATCGTTTTGGATGGAATAGCATGATGGTTGGCTTTTCATTAGCGGGTCTTGGTCTTTTACAC
TCAGTATTCCAAGCCTTTGTGGCAGGAAGAATAGCCACTAAATGGGGCGAAAAAACGGCAG
TACTGCTCGGATTTATTGCAGATAGTAGTGCATTTGCCTTTTTAGCGTTTATATCTGAAGGTT
GGTTAGTTTTCCCTGTTTTAATTTTATTGGCTGGTGGTGGGATCGCTTTACCTGCATTACAGGG
AGTGATGTCTATCCAAACAAAGAGTCATCAGCAAGGTGCTTTACAGGGATTATTGGTGAG
CCTTACCAATGCAACCGGTGTTATTGGCCCATTACTGTTTGCTGTTATTTATAATCATTCACT
ACCAATTTGGGATGGCTGGATTTGGATTATTGGTTTAGCGTTTTACTGTATTATTATCCTGCT
ATCGATGACCTTCATGTTAACCCCTCAAGCTCAGGGGAGTAAACAGGAGACAAGTGCTTAG
TAAGCGGGACTCTGGGGTTCGAAATGACCGACGGCTCACCTTCGGGTGGGCCTTTCTGCGA
GGAAGTTCCTATACTTTCTAGAGAATAGGAACTTCCGCTTGAGATATGCAGGTGT
E. coli glmS HR1 GGTCTCGCTACCGCGCTGGAAGGCGCATTGAAGTTGAAAGAGATCTCTTACATTCACGCTGA
AGCCTACGCTGCTGGCGAACTGAAACACGGTCCGCTGGCGCTAATTGATGCCGATATGC
CGGTTATTGTTGTTGCACCGAACAACGAATTGCTGGAAAAACTGAAATCCAACATTGAAG
AAGTTCGCGCGCGTGGCGGTCAGTTGTATGTCTTCGCCGATCAGGATGCGGGTTTTGTAAG
TAGCGATAACATGCACATCATCGAGATGCCGCATGTGGAAGAGGTGATTGCACCGATCTT
CTACACCGTTCCGCTGCAGCTGCTGGCTTACCATGTCGCGCTGATCAAAGGCACCGACGT
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was confirmed by colony PCR with glmS screen F and
glmS screen R, and by patching colonies to LB agar
plates with and without tetracycline (10 μg.mL− 1) The
antibiotic-sensitive clones were sub-cultured on LB agar
at 42 °C to remove pCP20, which has a temperature-
sensitive origin of replication. Absence of all plasmids
was confirmed by testing the colonies’ sensitivity to all
relevant antibiotics and the final modified strain was
verified by whole-genome shotgun sequencing.
Whole genome and whole plasmid shotgun sequencing
Genomic DNA was purified using a FastDNA Spin Kit for
feces (MP Bio, Santa Ana, CA, U.S.A.) according to the
manufacturer’s instructions, except that the final elution
was in 200 μL of DNAse-free water rather than 60 μL.
Plasmids were purified with a NucleoSpin Plasmid Mini-
prep kit (Macherey-Nagel, Düren, Germany). The DNA
was quantified using a Quant-iT dsDNA high sensitivity
assay kit (Thermo Fisher, Waltham, MA, U.S.A.) and nor-
malised to 0.2 ng.μL− 1 in 10mM Tris-HCl. Sequencing li-
braries were prepared with the Nextera XT DNA Library
Prep kit (Illumina, San Diego, CA, U.S.A.). Libraries were
quantified using the Quant-iT dsDNA high sensitivity
assay kit. Genome samples were pooled in equal quan-
tities, while plasmid libraries were first pooled together
and the whole plasmid pool was added to the genomic
pool at one-tenth the quantity of a genomic sample. The
final pool was then run at a concentration of 1.8 pM on
an Illumina NextSeq 500 instrument using a mid-output
sequencing kit for 150 bp paired-end reads. Sequences
were quality checked by FastQC v0.11.7 and trimmed with
Trimmomatic v0.36 with a minimum read length of 40 bp
and a sliding window of 4 bp with average quality of 15.
The reads were then mapped against the expected se-
quence for each sample in Geneious Prime 2019 with the
Geneious mapper and default settings.
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Table 2 Primers and chemically synthesized DNA fragments used in this study (Continued)
Primer/fragment name Sequence
TGACCAGCCGCGTAACCTGGCAAAATCGGTTACGGTTGAGTAATAAATGGATGCCCTGCG
TAAGCGGGGGGAGGGAGACC
E. coli glmS HR2 GGTCTCGAGGTCATTTTTCTTCCTGTTATGTTTTTAATCAAACATCCTGCCAACTCCATGTGAC
AAACCGTCATCTTCGGCTACTTTTTCTCTGTCACAGAATGAAAATTTTTCTGTCATCTCTTCGTT
ATTAATGTTTGTAATTGACTGAATATCAACGCTTATTTAAATCAGACTGAAGACTTTATCTCTCT
GTCATAAAACTGTCATATTCCTTACATATAACTGTCACCTGTTTGTCCTATTTTGCTTCTCGTAG
CCAACAAACAATGCTTTATGAATCCTCCCAGGAGACATTATGAAAGTTATGCGTACCACCG
TCGCAACTGTTGTCGCCGCGACCTTATCGATGAGTGCTTTCTCTGTGTTTGCAGAAGCAAG
CCTGACAGGTGCAGGTGCAACCTTCCCTGCGCCGGTGTATGCCAAATGGGACGAGGAGACC
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